Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Rioufol

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Current Radiopharmaceuticals|January 15, 2019
Feasibility and Evaluation of Automated Methods for Radiolabeling of Radiopharmaceutical Kits with Gallium-68Alban Revy, François Hallouard, Sandrine Joyeux-Klamber, et al.
Clinical Pharmacokinetics|August 5, 2009
Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluationEmilie Hénin, Michel Tod, Véronique Trillet-Lenoir, et al.
Journal of Medical Economics|September 14, 2012
Budget impact analysis of the use of oral and intravenous anti-cancer drugs for the treatment of HER2-positive metastatic breast cancerLaure Benjamin, Valérie Buthion, Michaël Iskedjian, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 20, 2024
Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and CostsTess Martin, Catherine Rioufol, Bertrand Favier, et al.
BMJ Open|February 17, 2024
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled studyLaure Huot, Pascale Guerre, Guillaume Descotes, et al.
JCO Oncology Practice|June 17, 2020
Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) GuidelinesBertrand Pourroy, Jean Francois Tournamille, Christophe Bardin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2020
Clinical and economic impact of medication reconciliation in cancer patients: a systematic reviewChloé Herledan, Amandine Baudouin, Virginie Larbre, et al.
Journal of Evaluation in Clinical Practice|February 1, 2018
Human-simulation-based learning to prevent medication error: A systematic reviewLaura Sarfati, Florence Ranchon, Nicolas Vantard, et al.
Hematological Oncology|May 30, 2020
Drug cost savings in phase III hematological oncology clinical trials in a university hospitalChloé Herledan, Florence Ranchon, Vérane Schwiertz, et al.
Nuclear Medicine Communications|November 26, 2019
Compatibility of [99mTc]Tc-EDDA/HYNIC-TOC and [68Ga] Ga-DOTA-TOC in a syringe for intravenous administrationSarah Chaib, François Hallouard, Philip Chennell, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Current Radiopharmaceuticals|January 15, 2019
Feasibility and Evaluation of Automated Methods for Radiolabeling of Radiopharmaceutical Kits with Gallium-68Alban Revy, François Hallouard, Sandrine Joyeux-Klamber, et al.
Clinical Pharmacokinetics|August 5, 2009
Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluationEmilie Hénin, Michel Tod, Véronique Trillet-Lenoir, et al.
Journal of Medical Economics|September 14, 2012
Budget impact analysis of the use of oral and intravenous anti-cancer drugs for the treatment of HER2-positive metastatic breast cancerLaure Benjamin, Valérie Buthion, Michaël Iskedjian, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 20, 2024
Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and CostsTess Martin, Catherine Rioufol, Bertrand Favier, et al.
BMJ Open|February 17, 2024
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled studyLaure Huot, Pascale Guerre, Guillaume Descotes, et al.
JCO Oncology Practice|June 17, 2020
Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) GuidelinesBertrand Pourroy, Jean Francois Tournamille, Christophe Bardin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2020
Clinical and economic impact of medication reconciliation in cancer patients: a systematic reviewChloé Herledan, Amandine Baudouin, Virginie Larbre, et al.
Journal of Evaluation in Clinical Practice|February 1, 2018
Human-simulation-based learning to prevent medication error: A systematic reviewLaura Sarfati, Florence Ranchon, Nicolas Vantard, et al.
Hematological Oncology|May 30, 2020
Drug cost savings in phase III hematological oncology clinical trials in a university hospitalChloé Herledan, Florence Ranchon, Vérane Schwiertz, et al.
Nuclear Medicine Communications|November 26, 2019
Compatibility of [99mTc]Tc-EDDA/HYNIC-TOC and [68Ga] Ga-DOTA-TOC in a syringe for intravenous administrationSarah Chaib, François Hallouard, Philip Chennell, et al.
Pageof 8